Demant
Health Care Equipment
Denmark
ESRS disclosure: ESRS E1 \ DR E1-1 \ Paragraph 16 a
Tags Tree
Selected: 0
No matching results found.
- Provide an explanation of how your company's greenhouse gas emission reduction targets align with the objective of limiting global warming to 1.5°C, as stipulated by the Paris Agreement, in accordance with Disclosure Requirement E1-1 regarding the transition plan for climate change mitigation.
-
Question Id: E1-1_02
Demant's Transition Plan consolidates the existing climate change mitigation plans and initiatives and details the different mitigation actions set by the Group to reduce the GHG emissions and reach our climate targets aligned with the Paris Agreement. The benchmarks provide a roadmap to ensure that company activities are consistent with the Paris Agreement’s objectives, particularly the goal of limiting the global temperature rise to 1.5°C above pre-industrial levels.
Report Date: 4Q2024Relevance: 85%
- What is the percentage of contractual instruments utilized for the sale and purchase of unbundled energy attribute claims in relation to Scope 2 GHG emissions? Provide details on the share and types of these contractual instruments, considering both location-based and market-based methods for calculating Scope 2 GHG emissions, as outlined in Disclosure Requirement E1-9.
-
Question Id: E1-6_22
35% of the Group’s electricity consumption is now covered by renewable sources, mainly from electricity vendors (directly sourced) and Energy Attribute Certificates.
Report Date: 4Q2024Relevance: 60%